QualityStocksNewsBreaks Archives - Page 577 of 1454

WednesdayOct 20, 2021 3:28 pm

QualityStocksNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Showcasing Innovations in OSA Treatment at 2021 Annual Breathing Wellness Conference

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from mild to moderate obstructive sleep apnea (“OSA”) and snoring, has announced the commencement of the 3rd-annual Breathing Wellness Conference presented by The Vivos Institute. The event is taking place at Caesars Palace in Las Vegas, Nevada, from Oct. 20-23, 2021, where dentists and medical doctors from around the world will hear from the industry’s top experts on OSA about its impact on chronic conditions such as heart disease, chronic fatigue and dementia. Attendees will also have the opportunity learn how innovations…

WednesdayOct 20, 2021 2:07 pm

QualityStocksNewsBreaks – Moon Equity Holdings Corp. (MONI) Closing Gender Gap in Tech with All-Female Advisory Board

Moon Equity Holdings (OTC: MONI), a pioneer within the global fintech sector, is looking to leverage its diverse management team — including its all-female advisory board — to create solutions that appeal to a wide range of markets in an effort to enhance customer experience, build a loyal following, generate repeat business, and make an impact on technology. MONI also aims to contribute to raising the ranks of women in fintech, joining organizations worldwide that are banding together to help close the gender gap in technology. The company has CEO Alison Galardi at the helm and an all-female advisory board…

WednesdayOct 20, 2021 1:47 pm

QualityStocksNewsBreaks – InnerScope Hearing Technologies Inc. (INND) Raises Buyers’ Interest, Showcases Unmatched Hearing Devices and Products During Recent Event

InnerScope Hearing Technologies (OTC: INND), an emerging and disruptive leader in the direct-to-consumer (“DTC”) hearing technology space, participated in the recent virtual Home Health & Diabetes Care Program — an event that connects sellers and corporate buyers. InnerScope raised buyers’ interest as the only company from the hearing device and hearing health care category to present at the event. During the event, the company showcased its broad range of unmatched direct-to-consumer hearing aids and accompanying products to corporate buyers from the home health care sector and some of the largest U.S. retailers, “including industry heavyweights such as CVS and Kroger…

WednesdayOct 20, 2021 1:16 pm

QualityStocksNewsBreaks – Avricore Health Inc.’s (TSX.V: AVCR) (OTCQB: AVCRF) HealthTab(TM) Platform Helping Reduce Patient Care Costs, Waiting Time

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) understands that up to 70% of all medical decisions are based on lab tests, which account for between 3% and 6% of total patient-care costs. The amount can be even more significant if a patient requires multiple tests or if the initial test proves unforthcoming. Avricore — which is focused on developing a network of point-of-care analyzers, offering advanced technologies that aid with easy, fast and efficient diagnosis — utilizes its HealthTab(TM) platform in community pharmacies, rural areas and workplaces to cut down on the time it takes for a patient to get a…

WednesdayOct 20, 2021 1:07 pm

QualityStocksNewsBreaks – FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) Targeting Early 2022 Rollout of Carbon-Free NH3 Demonstration Programs

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) is looking to change the energy landscape through its flagship project, which entails using its proprietary, first-of-its-kind technology to produce carbon-free ammonia (“NH3”). The company aims to change the narrative around the current carbon-intense and energy-intense Haber-Bosch process of industrially synthesizing NH3. A recent article quotes NHHHF CEO Ian Clifford as saying, “Our system is entirely carbon-free… We take sustainable electricity, water and air, and we produce carbon-free NH3, which can be utilized across multiple industries as an extremely versatile material… We are now just in the process of commercializing the technology, and we plan…

WednesdayOct 20, 2021 12:49 pm

QualityStocksNewsBreaks – Friendable Inc. (FDBL) Commences Digital Campaign to Promote Brand, Make Fan Pass a Household Name

Friendable (OTC: FDBL), a mobile technology and marketing company, recently released 15- and 30-second radio spots on Spotify and other programmatic networks as part of its 120-day strategy, which also included the release of version 2.0 of the Fan Pass platform. Following the release of the all-new version, Friendable took the necessary steps to ensure a stable platform and sound service offerings. “Now, it’s time to begin promoting our brand and mission with the release of these two radio spots, which are just beginning to run on various networks including Spotify,” a recent article quotes Friendable CEO Robert A. Rositano…

WednesdayOct 20, 2021 12:16 pm

QualityStocksNewsBreaks – Save Foods Inc. (NASDAQ: SVFD) Announces Validation of Pre-Harvest Applications of Its Treatments by Leading California Academic Institution

Save Foods (NASDAQ: SVFD), an Israeli-based agrifood tech company focused on developing and selling eco-friendly products specifically designed to extend the shelf life and ensure the safety of fresh fruits and vegetables, today announced the completion of a series of successful trials in conjunction with a leading California academic institution. Save Foods is collaborating with several plant pathologists and researcher labs as part of its efforts to validate the efficacy of its products. Recently, a world-renowned academic institution in California validated the efficacy and impact of Save Foods’ treatments as a pre-harvest application. Results from the study demonstrate pre-harvest applications…

WednesdayOct 20, 2021 11:05 am

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Study Reveals Effectiveness of Proprietary Drug-Development Tech

Lexaria Bioscience (NASDAQ: LEXX), developers of the revolutionary DehydraTECH(TM) drug-delivery technology, has released study results focused on THC-A21-1, a THC oral format. According to the announcement, the study showed that Lexaria’s DehydraTECH THC solution delivers THC levels to blood plasma an estimated three times faster than standard MCT-based THC. Based on study results, it took only 15 minutes using oral ingestion of the substance to reach THC levels comparable to those reached in 45 minutes using "coconut-oil" formulations. As the THC left the system at the six-hour mark, levels were comparable and demonstrated the fast-on, fast-off performance. The DehydraTECH results are timely…

WednesdayOct 20, 2021 10:33 am

QualityStocksNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Granted Approval to Evaluate Sensory Factors in Product-Development Trials

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) has received an amendment to a cannabis research license it had previously been granted by Health Canada. The amendment allows the company to include sensory evaluations of cannabis beverages in an upcoming product development trial. According to the announcement, the company will be able to conduct onsite human assessments of the taste, smell, feel and visual appeal of products the company is developing, a move that BevCanna says will provide significant advantages for its white-label clients as well as in-house brands because the new-product trial capabilities are unique in the Canadian cannabis beverage…

TuesdayOct 19, 2021 3:01 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Impacting the Pharmaceutical Industry

Lexaria Bioscience Corp. (NASDAQ: LEXX) has remained committed to enhancing the speed and overall efficiency of orally delivered fat-soluble active molecules. The company is leveraging its drug delivery technology, DehydraTECH(TM), in the development of hypertension and anti-viral treatments — a big achievement already making an impact in the pharmaceutical industry. “Since Lexaria began working on this technology in 2014, DehydraTECH has developed considerably and impacted the industry. So far, it has proven useful for potentially treating hypertension, along with the delivery of colchicine, a drug with known SARS-CoV-2 anti-viral properties,” reads a recent article. “DehydraTECH is applied by incorporating an…

Site Search

Company Search

Category: QualityStocksNewsBreaks